India required 66.6 crores of coronavirus vaccine doses to vaccinate 30 crore people
India COVID-19 vaccine
India : Indian drug regulator approved the Oxford-AstraZeneca COVID-19 vaccine dubbed ‘Covishied’, in India and is manufactured by Serum Institute and Bharat Biotech’s Covaxin for emergency use in the country. While Covishied has been approved for individuals above 18 years, Covaxin has been approved for children above 12 years - both the vaccines need to be administered in two doses.
India will need to obtain 66.6 crores of coronavirus vaccine doses to vaccinate 30 crore people, and not just 60 crore doses as initially planned. According to a report, the Union Health Ministry has come up with a formula to estimate the number of vaccines the government would require to vaccinate the masses as manufacturers begin rolling out their jabs.
According to a report in TOI citing the formula, the Centre would need 111 doses to buy 111 doses to vaccinate every 50 beneficiaries. This translates to 66.6 crores of doses in order to administer two doses of a vaccine to 30 crore individuals.
The report added that guidelines issued to all state governments suggest the formula used to estimate vaccine requirements at various levels - such as block, district and state - has been borrowed broadly from the Universal Immunization Programme.